Latest news
Fake Data May Now Cost Pharma Firms Regulatory Access, Centre Warns - Outlook IndiaOutlook India · Fri, 07 Aug 2026 07:42:25 GMTGovt cracks whip on fake data submissions, to debar pharma firms for non-compliance - ET NowET Now · Fri, 07 Aug 2026 07:24:33 GMTCentre introduces stricter penalties for fake data in drug applications - SME FuturesSME Futures · Fri, 07 Aug 2026 06:55:59 GMTHealth Ministry empowers drug regulators to debar applicants submitting fake data - Indian Pharma PostIndian Pharma Post · Fri, 07 Aug 2026 06:06:22 GMTIndia Tightens Drug Rules to Debar Applicants Submitting Fake Data - Voice of HealthcareVoice of Healthcare · Fri, 07 Aug 2026 06:00:00 GMTCentre Amends Drugs Rules to Debar Applicants Submitting Fake Regulatory Data - Daily PioneerDaily Pioneer · Fri, 07 Aug 2026 02:37:11 GMTUnder new rules, pharma firms to get debarred for submitting fabricated data - The TribuneThe Tribune · Fri, 07 Aug 2026 02:04:25 GMTHealth Ministry tightens drug approval norms, introduces debarment for fake data submissions - The Indian AwaazThe Indian Awaaz · Thu, 06 Aug 2026 19:22:00 GMT